Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082]
更正“在 INTERCEPT-AD 中,早期阿尔茨海默病 1 期试验中,使用 sabirnetug (ACU193) 治疗后生物流体生物标志物的变化”[J Prev Alzheimers Dis 2025;12(4): 100082]
期刊:Jpad-Journal of Prevention of Alzheimers Disease
影响因子:7.8
doi:10.1016/j.tjpad.2025.100217
Cline, Erika N; Antwi-Berko, Daniel; Sundell, Karen; Johnson, Elizabeth; Hyland, Maddelyn; Zhang, Hao; Vanderstichele, Hugo; Kaplow, June; Dean, Robert A; Stoops, Erik; Vanmechelen, Eugeen; Koel-Simmelink, Marleen J A; Teunissen, Charlotte E; Sethuraman, Gopalan; Feaster, Todd; Siemers, Eric; Jerecic, Jasna